Apolipoprotein E influences amyloid-beta clearance from the murine periphery

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• The metabolism and clearance of amyloid-beta protein (Abeta) in Alzheimer's disease (AD) pathogenesis are not fully understood.
• Apolipoprotein E (apoE) E4 isoform is linked to impaired Abeta clearance in vitro, potentially due to reduced binding affinity.
• In vivo validation is crucial to confirm the role of apoE isoforms in Abeta clearance.

Purpose of the Study:

• To investigate the in vivo clearance of amyloid-beta protein (Abeta) from the periphery.
• To determine the influence of apolipoprotein E (apoE) on Abeta clearance rates and organ sequestration.
• To compare Abeta clearance in mice expressing apoE versus those lacking apoE.

Main Methods:

• Peripheral injection of Abeta into C57BL/6J (apoE-expressing) and APOE knockout mice.
• Measurement of Abeta plasma half-life over time using Western blot analysis.
• Quantification of Abeta sequestration in peripheral organs (liver, kidneys) at 90 minutes post-injection.

Main Results:

• Amyloid-beta protein (Abeta) exhibited a plasma half-life of approximately 15 minutes in mice.
• C57BL/6J mice sequestered ~40% of injected Abeta in the liver and 5% in the kidneys within 90 minutes.
• APOE knockout mice showed no detectable Abeta in the liver or kidneys, indicating impaired clearance.

Conclusions:

• Amyloid-beta protein (Abeta) is rapidly cleared from the plasma via peripheral tissues in mice.
• The presence of apolipoprotein E (apoE) significantly affects the rate and extent of Abeta peripheral clearance.
• These findings highlight apoE's critical role in vivo Abeta metabolism, relevant to Alzheimer's disease research.